Patent: 10,359,432
✉ Email this page to a colleague
Summary for Patent: 10,359,432
Title: | Methods for detecting antibodies |
Abstract: | Complexes comprising a therapeutic monoclonal antibody and a peptide are provided. In some embodiments, the complexes may comprise a therapeutic monoclonal antibody which is not complexed to an epitope of a target protein and a peptide complexed to the therapeutic monoclonal antibody. In some embodiments, the peptide may have a length of about 5-40 amino acids and may comprise a mimetope recognized by the therapeutic monoclonal antibody, wherein the mimetope comprises a linear sequence of amino acids which is different than a linear sequence of amino acids in the epitope of the target protein. |
Inventor(s): | Kipps; Thomas J. (San Diego, CA), Messmer; Bradley T. (San Diego, CA), Sanchez; Ana B. (Encinitas, CA), Kummel; Andrew C. (San Diego, CA), Ruidiaz; Manuel (La Jolla, CA) |
Assignee: | The Regents of the University of California (Oakland, CA) |
Application Number: | 14/981,715 |
Patent Claims: | see list of patent claims |
Details for Patent 10,359,432
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 05/07/2001 | ⤷ Try a Trial | 2028-03-27 |
Genzyme Corporation | LEMTRADA | alemtuzumab | Injection | 103948 | 11/14/2014 | ⤷ Try a Trial | 2028-03-27 |
Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 10/12/2004 | ⤷ Try a Trial | 2028-03-27 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |